Transactions


The Guidance Notes below cover a broad range of applied knowledge in respect of transactions that has been provided to our clients, and updated to reflect the companies’ feedback and practical experience.

  • GNT 3: Licensing

    This guidance note sets out in overview of the most common tax implications arising in Life Science licensing. By reviewing the key components of the transaction at Heads of Terms, a number of potential issues can be ruled out, allowing focus to be applied to key aspects and the parties to agree terms when negotiations are more fluid. (Password required)

    MORE

  • GNT 4: Deferred Consideration

    This guidance note sets out in overview of the most common tax implications arising in Life Science licensing. By reviewing the key components of the transaction at Heads of Terms, a number of potential issues can be ruled out, allowing focus to be applied to key aspects and the parties to agree terms when negotiations are more fluid. (Password required)

    MORE

  • GNT 20: Substantial Shareholdings Exemption

    The Substantial Shareholding Exemption allows a company to dispose of shares without corporation tax consequences where certain conditions are met. This can be a highly valuable benefit for companies looking to partner one or more assets while retaining others. Any gain on disposal is exempt and any loss is not deductible. This Guidance Note provides an overview of the detailed rules together with a practical insight into their application. (Password required)

    MORE

  • GNT 21: Tax Efficient Divestment

    This Guidance Note covers the basic options for pre-disposal tax planning for tax efficient realisation where a company may wish to sell or partner one programme and retain others. These balance the conflicting demands mitigating, where possible, a double charge arising at corporate and shareholder levels and the complexity and cost of the planning. (Password required)

    MORE

  • GNT 39: Demergers

    This Guidance Notes focuses on the tax implications of the different types of demerger structures that UK companies typically adopt to split their activities into two or more separate companies. There are three ways of achieving tax neutrality when implementing a demerger. Groups should carefully consider the options available to them and the requirements that need to be satisfied to obtain tax relief. (Password required)

    MORE

More Info

Share this page

Inside N-Site

Subscribe Now

Up-to-date information on tax developments within the UK Life Sciences Industry.

Subscribe

Request a Guidance Note

More

FTI N-Site Information

More